Tag: Side Effects
Adverse Effects Generally Mild After BNT162b2 mRNA Booster in Over 60s
Thirty percent of those aged 60 years or older receiving booster reported at least one AE; few sought medical attention
Women Face Higher Risk for Severe AEs From Cancer Therapy
Large differences in risks for severe adverse events according to sex seen for cancer patients receiving immunotherapy
Methotrexate-Related AEs Profiled in Early Rheumatoid Arthritis
Adverse events common during first year of methotrexate therapy for early rheumatoid arthritis, but most not serious
Survivors of Severe COVID-19 Report Many Long-Term Symptoms
Findings show physical, mental, and cognitive symptoms one year after ICU stay for COVID-19
Thrombosis, Thrombocytopenia Syndrome Up After Ad26.COV2.S
Reporting rates 3.83 per million vaccine doses for Ad26.COV2.S versus 0.00855 per million for mRNA-based vaccines
Risk for Carditis Tied to Second Dose of Pfizer-BioNTech COVID-19 Vaccine
No such increased risk seen with Sinovac inactivated virus vaccine
Serious Adverse Effects From COVID-19 Vaccines Reported Rarely
Full vaccination dose, younger age, female sex, and previously having had COVID-19 linked to greater odds of adverse effects
Adverse Events Rare After BNT162b2 Vaccine in 5- to 11-Year-Olds
Data show 4,249 reports of adverse events after about 8.7 million doses of vaccine were administered; 97.6 percent not serious
Adverse Events Associated With BNT162b2 Vaccination ID’d
Vaccination not associated with elevated risk for most of the adverse events examined; association found with increased risk for myocarditis, but risk higher in association with SARS-CoV-2 infection
For U.S. Teens, Most Adverse Events to COVID-19 Vaccine Nonserious
Frequency of local, systemic reactions reported for teens enrolled in v-safe similar to preauthorization clinical trials
